Related Experiment Video
Updated: Aug 27, 2025

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Increased serum resistin levels associated with isolated coronary artery ectasia
1Department of Cardiology, Hatay Dortyol Hospital, Hatay, Turkey.
Insights
Elevated serum resistin levels are significantly associated with coronary artery ectasia (CAE). Higher resistin levels correlate with the number of affected coronary arteries, suggesting a role in CAE development.
Area of Science:
- Cardiology
- Endocrinology
- Biochemistry
Background:
- Coronary artery ectasia (CAE) is defined as abnormal coronary artery enlargement, with unclear etiology and pathophysiology.
- Resistin, an adipokine linked to inflammation, is a potential factor in disease development.
Purpose of the Study:
- To investigate the association between serum resistin levels and coronary artery ectasia (CAE).
- To determine if resistin plays a role in the etiopathogenesis of CAE.
Main Methods:
- A comparative study included 103 patients with CAE and 122 with normal coronary anatomy (NCA).
- Clinical characteristics, angiographic findings, and biochemical parameters, including serum resistin levels, were analyzed.
Main Results:
- Serum resistin levels were significantly higher in patients with CAE compared to NCA (p=0.001).
- Hypertension, tobacco use, hyperlipidemia, triglyceride levels, and serum resistin were independent risk factors for CAE.
- Resistin levels increased with the number of coronary arteries affected by ectasia.
- ROC analysis indicated serum resistin had 67.6% sensitivity and 86.7% specificity for CAE (AUC=0.749).
Conclusions:
- Serum resistin levels are significantly elevated in patients with coronary artery ectasia.
- Resistin levels are directly proportional to the extent of coronary artery ectasia.
- Further research is warranted to elucidate the role of resistin in CAE.
Introduction:
Coronary artery ectasia (CAE) is localized or diffuse enlargement of the coronary artery more than 1.5 times in diameter in comparison with the adjacent normal coronary artery. The etiology and pathophysiology of CAE are not fully elucidated. Resistin is a newly identified adipocyte secreted hormone belonging to a cysteine-rich protein family. Recently it has been found to be relevant to inflammation-related disease and correlated with serum C-reactive protein (CRP). This research aimed to investigate whether the resistin level has a role in CAE etiopathogenesis.
Material And Methods:
A hundred and three patients with diagnosis of CAE and 122 with normal coronary anatomy (NCA) were included. Details of baseline clinical characteristics and angiographic findings were recorded. Other necessary biochemical parameters were measured with an autoanalyzer. Blood was collected and stored for serum resistin level analysis.
Results:
Serum resistin levels in CAE were higher than in the NCA group and were statistically significant (p = 0.001). Hypertension (OR = 1.006, 95% CI: 1.002-1.008, p = 0.025), tobacco use (OR = 1.089, 95% CI: 1.055-1.124, p < 0.001), serum resistin levels (OR = 2.431, 95% CI: 1.100-4.696, p = 0.01), hyperlipidemia (OR = 1.005, 95% CI: 1.000-1.014, p = 0.004), triglyceride (OR = 1.006, 95% CI: 1.001-1.010, p = 0.012) remained as independent factors for CAE. In the subgroup analysis of the CAE group, in patients with ectasia in three coronary arteries, resistin levels were significantly higher and statistically significant (p = 0.001). In ROC analysis, the sensitivity of serum resistin was 67.6% and specificity was 86.7% (AUC = 0.749, 95% CI: 0.621-0.877, p = 0.0001).
Conclusions:
Serum resistin level was significantly higher in CAE. In addition this study showed that serum resistin levels are directly proportional to the number of coronary arteries with ectasia. We think that this study will shed light on this subject and encourage further studies in this field.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction

